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Enzymes of the AlkB and CYP153 families catalyze the first step in the catabolism of medium-chain-length
alkanes, selective oxidation of the alkane to the 1-alkanol, and enable their host organisms to utilize alkanes
as carbon sources. Small, gaseous alkanes, however, are converted to alkanols by evolutionarily unrelated
methane monooxygenases. Propane and butane can be oxidized by CYP enzymes engineered in the laboratory,
but these produce predominantly the 2-alkanols. Here we report the in vivo-directed evolution of two medium-
chain-length terminal alkane hydroxylases, the integral membrane di-iron enzyme AlkB from Pseudomonas
putidaGPo1 and the class II-type soluble CYP153A6 fromMycobacterium sp. strain HXN-1500, to enhance their
activity on small alkanes. We established a P. putida evolution system that enables selection for terminal alkane
hydroxylase activity and used it to select propane- and butane-oxidizing enzymes based on enhanced growth
complementation of an adapted P. putida GPo12(pGEc47B) strain. The resulting enzymes exhibited higher
rates of 1-butanol production from butane and maintained their preference for terminal hydroxylation. This
in vivo evolution system could be useful for directed evolution of enzymes that function efficiently to hydroxylate
small alkanes in engineered hosts.
Microbial utilization and degradation of alkanes was discov-
ered almost a century ago (27). Since then, several enzyme
families capable of hydroxylating alkanes to alkanols, the first
step in alkane degradation, have been identified and catego-
rized based on their preferred substrates (30). The soluble and
particulate methane monooxygenases (sMMO and pMMO)
and the related propane monooxygenase and butane mono-
oxygenase (BMO) are specialized on gaseous small-chain al-
kanes (C1 to C4), while medium-chain (C5 to C16) alkane
hydroxylation seems to be the domain of the CYP153 and
AlkB enzyme families.
Conversion of C1 to C4 alkanes to alkanols is of particular
interest for producing liquid fuels or chemical precursors from
natural gas. The MMO-like enzymes that catalyze this reaction
in nature, however, exhibit limited stability or poor heterolo-
gous expression (30) and have not been suitable for use in a
recombinant host that can be engineered to optimize substrate
or cofactor delivery. Alkane monooxygenases often cometabo-
lize a wider range of alkanes than those which support growth
(12). We wished to determine whether it is possible to engineer
a medium-chain alkane monooxygenase to hydroxylate small
alkanes, thereby circumventing difficulties associated with en-
gineering MMO-like enzymes as well as investigating the fun-
damental question of whether enzymes unrelated to MMO can
support growth on small alkanes.
The most intensively studied medium-chain alkane hydroxy-
lases are the AlkB enzymes (2, 20, 29), especially AlkB from
Pseudomonas putida GPo1 (13, 28, 32, 35). While most mem-
bers of the AlkB family act on C10 or longer alkanes, some
accept alkanes as small as C5 (30). A recent study (12) indi-
cated that AlkB from P. putida GPo1 may also be involved in
propane and butane assimilation. AlkB selectively oxidizes at
the terminal carbon to produce the 1-alkanols. No systematic
protein engineering studies have been conducted on this di-
iron integral membrane enzyme, although selection and site-
directed mutagenesis efforts identified one amino acid residue
that sterically determines long-chain alkane degradation (35).
The most recent addition to the known biological alkane-
hydroxylating repertoire is the CYP153 family of heme-con-
taining cytochrome P450 monooxygenases. Although their ac-
tivity was detected as early as 1981 (1), the first CYP153 was
characterized only in 2001 (16). Additional CYP153 enzymes
were identified and studied more recently (9, 10, 31). These
soluble class II-type three-component P450 enzymes and the
AlkB enzymes are the main actors in medium-chain-length
alkane hydroxylation by the cultivated bacteria analyzed to
date (31). CYP153 monooxygenases have been the subject of
biochemical studies (9, 16, 19), and their substrate range has
been explored (10, 14). Known substrates include C5 to C11
alkanes. The best-characterized member, CYP153A6, hydroxy-
lates its preferred substrate octane predominantly (95%) at
the terminal position (9).
Recent studies have shown that high activities on small al-
kanes can be obtained by engineering bacterial P450 enzymes
such as P450cam (CYP101; camphor hydroxylase) and P450
BM3 (CYP102A; a fatty acid hydroxylase) (8, 36). The result-
ing enzymes, however, hydroxylate propane and higher alkanes
primarily at the more energetically favorable subterminal po-
sitions; highly selective terminal hydroxylation is difficult to
achieve by engineering a subterminal hydroxylase (22). We
wished to determine whether a small-alkane terminal hydrox-
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ylase could be obtained instead by directed evolution of a
longer-chain alkane hydroxylase that exhibits this desirable
regioselectivity. For this study, we chose to engineer AlkB from
P. putida GPo1 and CYP153A6 from Mycobacterium sp. strain
HXN-1500 (9, 33) to enhance activity on butane. Because
terminal alkane hydroxylation is the first step of alkane catab-
olism in P. putida GPo1, we reasoned that it should be possible
to establish an in vivo evolution system that uses growth on
small alkanes to select for enzyme variants exhibiting the de-
sired activities.
The recombinant host Pseudomonas putida GPo12(pGEc47B)
was engineered specifically for complementation studies with
terminal alkane hydroxylases and was used previously to char-
acterize members of the AlkB and CYP153 families (26, 31).
This strain is a derivative of the natural isolate P. putida GPo1
lacking its endogenous OCT plasmid (octane assimilation) (5)
but containing cosmid pGEc47B, which carries all genes com-
prising the alk machinery necessary for alkane utilization, with
the exception of a deleted alkB gene (34). We show that this
host can be complemented by a plasmid-encoded library of
alkane hydroxylases and that growth of the mixed culture on
butane leads to enrichment of novel butane-oxidizing terminal
hydroxylases.
MATERIALS AND METHODS
Strains and growth conditions. The strains and plasmids used in this study are
listed in Table 1. Luria-Bertani broth (23) and modified M9 medium with 1.5%
yeast extract (8) supplemented with appropriate antibiotics, or E2 (15) and M9
(17) minimal media supplemented with carbon sources, were used for growth.
All cultures were grown aerobically at 30°C (P. putida) or 37°C (Escherichia coli).
Antibiotic concentrations were 100 g/ml ampicillin, 15 g/ml tetracycline, 20
g/ml chloramphenicol, and 10 g/ml gentamicin for E. coli cultures and 50
g/ml for pseudomonads. Bacterial strains were grown on solid E2 minimal
medium with liquid alkanes (Sigma-Aldrich) provided through the gas phase as
described previously (26). Solid minimal medium growth tests on gaseous al-
kanes (Sigma-Aldrich) were conducted in gas-tight plastic containers (GasPak
150 large anaerobic vented system; VWR), pressurized at 20 lb/in2 for 20 s
(ethane and propane) or 10 lb/in2 for 6 s (butane). Liquid minimal medium
cultures growing on alkanes were shaken in custom-made gas-tight flasks with
1% liquid alkane (pentane and octane) in a reservoir or in gas-tight serum bottles
(Alltech), pressurized with gaseous alkanes as described above. For growth tests
of P. putida GPo12(pGEc47B) on alkanols (Sigma-Aldrich), cells from an LB
preculture were washed three times with M9 medium and used to inoculate the
5-ml M9 main cultures in 14-ml tubes (Greiner) to an optical density (OD) of
0.1, then grown at 30°C with continuous shaking. Libraries of P. putida
GPo12(pGEc47B) strains expressing AlkB or CYP153A6 variants were precul-
tured on E2 minimal medium plates with antibiotics and 0.2% (wt/vol) citrate as
carbon source and then enriched for improved strains through continuous
growth in liquid E2 minimal medium with small-chain-length alkanes as the sole
carbon source, as described above.
Transformation, cloning, and mutagenesis. E. coli DH5 strains used for plas-
mid amplification were transformed by electroporation (23), E. coli BL21(DE3)
(Novagen) was used for protein expression by heat shock according to the
manufacturer’s manual, and P. putida GPo12(pGEc47B) strains were trans-
formed by triparental mating with the appropriate E. coli DH5 donor and E.
coli CC118(pRK600) mediator strain (6). Plasmids pCom8_cyp153A6 and
pCom10_alkB were obtained from the B. Witholt (now retired) laboratory, ETH
Zurich. Sequencing of pCom8_cyp153A6 revealed it to be missing the first 9
nucleotides of the coding sequence of the monooxygenase gene compared to the
published sequence (9). The CYP153A6 parent enzyme and its variants are
therefore three N-terminal amino acids shorter than the published sequence but
are otherwise identical and obviously functional.
Mutagenesis of pCom plasmids was performed in E. coli XL1-Red strains
according to the manufacturer’s manual (Stratagene) and in E. coli JS200(pEP
Pol I) as described previously (3). Mutated alkB genes or the CYP153A6 gene
fdrA6 and fdxA6 operons were cloned into the original pCom10 or into pCom8*
plasmids as EcoRI-HindIII- or KpnI-digested fragments, respectively. Restric-
tion enzymes were obtained from Roche Molecular or New England Biolabs.
Plasmid pCom8_alkBFG was constructed by amplifying the alkBFG operon from
the plasmid pblaP4_alkJBFG-luxAB (18) using the primers alkBFG_1 (GAT
CTACATATGCTTGAGAAACACAGAGTTCTGGATTC) and alkBFG_2
(GATCTACCCGGGTCACTTTTCCTCGTAGAGCACATAGTC) in a stan-
dard PCR method. The resulting fragment was cloned into the pCom8 vector
using the NdeI and XmaI restriction sites introduced by the primers. The result-
ing plasmid was digested with SpeI, and the resulting alkB-containing 3.7-kb
fragment was replaced with the appropriate fragment from SpeI-digested
pCom10_alkB, pCom10_alkB-BMO1, and pCom10_alkB-BMO2 by cloning, re-
sulting in pCom8_alkBFG, pCom8_alkB-BMO1_alkFG, and pCom8_alkB-
BMO2_alkFG. Successful cloning was verified by sequencing.
Protein expression and bioconversions. E. coli BL21(DE3) cells expressing
AlkB variants were precultured in LB medium at 37°C with shaking at 250 rpm
for 24 h. LB cultures (120 ml) in 1,000-ml flasks were inoculated to an OD at 600
nm (OD600) of 1.0 and grown at 37°C, 250 rpm, for 2.5 h. The cultures were then
set to 25°C at 200 rpm and induced with 0.4 mM dicyclopropylketone (Sigma-
Aldrich) after 30 min. The cultures were centrifuged (10 min, 3,300  g, room
temperature) 20 h later and the cell pellets resuspended in an equal volume of
100 mM KPi buffer (pH 7.0). For cell dry weight determinations, 10-ml cell
suspensions were washed once with distilled water and the cell pellets were dried
for 3 days at 80°C. For bioconversion experiments with liquid alkanes, 250 l of
the alkane and 1% (vol/vol) glycerol were added to a 1-ml cell suspension in a
TABLE 1. Strains and plasmids used or constructed in this work
Strain or plasmid Relevant genotype or characteristics Reference and/or source
E. coli strains
CC118(RK600) Helper strain for triparental mating 6
DH5 Cloning strain Invitrogen
JS200(pEP Pol I) Mutator strain Addgene; 3
XL1-Red Mutator strain Invitrogen
P. putida strains
GPo12(pGEc47B) GPo1 cured of the OCT plasmid, transformed with pGEc47B; contains all genes necessary
for growth on alkanes, except for the alkane hydroxylase gene
26
Palk1 GPo12(pGEc47B) adapted to growth on gaseous alkanes with pCom10_alkB This study
Pcyp1 GPo12(pGEc47B) adapted to growth on gaseous alkanes with pCom8_cyp153A6 This study
Pcyp2 Pcyp1 further adapted to growth on gaseous alkanes with pCom8*_cyp153A6-BMO1 This study
Plasmids
pCom8 Broad-host-range expression vector with PalkB; Gmr oriT alkS 25
pCom8* pCom8 vector adapted for improved complementation for small-chain-length alkane-
dependent host growth
This study
pCom10 Broad-host-range expression vector with PalkB; Kanr oriT alkS 25
338 KOCH ET AL. APPL. ENVIRON. MICROBIOL.
glass vial (Kimax), capped, and incubated at a 60° angle at 25°C and 200 rpm.
After 60 min, reactions were stopped by addition of 200 l of 1 N HCl. Pentane
bioconversion samples were then left open at 60°C for 1 h to allow the substrate
to evaporate and subsequently pelleted, filtered, and subjected to gas chroma-
tography analysis. Octane bioconversion products were extracted by adding 250
l hexane, vortexing for 30 s, and centrifuging at 14,000 rpm for 10 min. Alkanols
were then detected in the top organic layer.
For bioconversions of gaseous alkanes, 80 ml of cell suspension and 15 l of
antifoam (Sigma-Aldrich) were stirred in a 100-ml bioreactor (Ochs-labor) at
25°C. Propane or butane was mixed in a 1:3 ratio with air, and the mixture was
fed to the cells at an inlet gas flow rate of approximately 10 liter h1. The
reaction was started by addition of glycerol to a final concentration of 1%
(vol/vol). After 30 min, 1-ml samples were taken from the cell suspension as well
as from the wash fraction of a bubbler installed downstream of the bioreactor,
combined, centrifuged, filtered, and subjected to gas chromatographic analysis.
Bioconversions with CYP153A6 variants were conducted as described above,
with the following modifications: cells induced for expression of CYP153 were
grown in modified M9 medium with 1.5% yeast extract for 14 h, and the buffer
used for bioconversions was modified M9 medium prepared without nitrogen.
Gaseous alkane and air were introduced at 1:1 (vol/vol) through a gas dispenser.
Bioconversions of liquid and gaseous alkanes were started by addition of 20 mM
glucose and stopped after 60 min. The concentration of properly folded P450
protein was determined from the CO difference spectrum of 5-concentrated
cell extract after sonication, removal of cell debris, and bubbling CO into the
sample. Addition of reducing agent to a concentrated cell extract was not nec-
essary and in fact decreased CO binding. To assess P450 stability, CO-binding
studies were performed on aliquots of cell extracts that had been stored at 25°C
for up to 24 h.
RESULTS
P. putida GPo12(pGEc47B) grows on short-chain 1-alkanols
but not the 2-alkanols. P. putida GPo12(pGEc47B) was shown
in previous studies to grow on medium-chain-length alkanols
like 1-octanol and on the corresponding alkane only when
complemented by a terminal alkane hydroxylase (26, 31). To
determine whether this strain could be used to select or screen
for improved terminal alkane hydroxylation activity, we tested
its ability to grow with the primary and secondary C1 to C8
alkanols as sole carbon sources (Fig. 1). No growth was ob-
served on any of the secondary alcohols or on methanol during
an 18-day period. Ethanol, 1-propanol, and 1-butanol sup-
ported relatively strong growth, comparable to that of the
positive control grown on glucose. Slow growth was observed
on 1-pentanol, 1-hexanol, and 1-octanol. The results indicated
that the terminal hydroxylation products of all the short-chain
n-alkanes except for methane are readily utilized as carbon
sources, while subterminal oxidation products (the sec-
alkanols) are not. Thus, this strain should be suitable for
growth-based screening and selection for terminal hydroxyla-
tion of alkanes of long, medium, and short chain lengths.
Creation of gene libraries through random plasmid muta-
tion. It was not efficient to use error-prone PCR to randomly
mutate the target genes, as cloning of PCR products into the
pCom vector yielded fewer than 2,000 transformants, much
less than the hundreds of millions of mutants that can be
evaluated in principle using a growth selection. Mutant librar-
ies were therefore constructed by complementing P. putida
GPo12(pGEc47B) strains with randomly mutated plasmids
encoding AlkB or CYP153A6. The drawbacks of including
mutations that affect the vector (antibiotic resistance and ori-
gin of replication) rather than just the inserted genes are com-
pensated for by the large size and ease of library construction.
Mutator strains were used to generate the plasmid libraries
and to increase diversity both available mutator strains were
used, Escherichia coli XL1-Red (Stratagene) and E. coli JS200
pEP polymerase I (Pol I) (4). E. coli XL1-Red has deficiencies
in the DNA repair mechanism that lead to a 5,000-fold in-
crease in the general mutation rate (11) (Stratagene manual).
E. coli JS200 pEP Pol I expresses an engineered mutator DNA
polymerase I which mainly amplifies plasmid DNA, with lower
reliability, thus introducing mutations in the plasmid DNA (4).
The nucleotide mutation level in XL1-Red after 2 weeks of
continuous culturing was approximately 0.1/kb, while four
rounds of mutation in JS200 pEP Pol I yielded up to 0.4/kb.
Cultures of both mutator strains were combined and the mutated
plasmids were transformed into P. putida GPo12(pGEc47B)
through triparental mating with the helper strain E. coli CC118
(pRK600) (31). The growth selection was performed by culturing
the resulting strain library in minimal medium with an alkane as
sole carbon source for up to 3 weeks, as described in Materials
and Methods.
P. putida GPo12(pGEc47B) strains grow faster on butane
when complemented with evolved AlkB and CYP153A6 vari-
ants. A mixed culture containing alkane hydroxylase variants
will become enriched in strains best adapted to use alkanes as
their sole carbon source. However, not only can beneficial
mutations in the hydroxylase gene lead to improved growth,
but also adaptations of the host and vector will do so as well.
For P. putida GPo12(pGEc47B) complemented by CYP153
genes, it had been observed that the host had to be adapted
through prolonged cultivation on alkanes to obtain significant
growth on these substrates (31), without any mutations occur-
ring in the CYP153 genes themselves. To test whether host
adaptation was also occurring in our experiments, 21 single
colonies obtained from the first round of enrichment cultures
were compared to the parent strain in plate growth tests (data
not shown). Solid medium growth tests were chosen over liquid
medium tests due to the growth instability of liquid minimal
medium cultures of P. putida GPo12(pGEc47B), which often
show different growth rates between replicates or, occasionally,
failure to grow at all. The host, vector, and operons of the best
mutants were analyzed individually by comparing them in
growth tests to their wild-type counterparts (see Fig. S1 in the
FIG. 1. Growth of P. putida GPo12(pGEc47B) with primary and
secondary linear short and medium chain-length alkanols. The OD600
of the cultures was measured after 18 days of growth in liquid M9
minimal medium with 0.5% (vol/vol) primary (CX-1-ol; X  number
of carbon atoms) or secondary (CX-2ol) alcohols as carbon source
dissolved in a 5% (vol/vol) organic layer of heptamethylnonane. Alco-
hols smaller than five carbon atoms were added without organic sol-
vent. Cultures with 0.5% (wt/vol) glucose or no added nutrient served
as controls.
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supplemental material). To identify and analyze potentially
adapted hosts, the adapted recombinant strain was cured of
the plasmid and transformed with the appropriate wild-type
plasmid. Adapted vectors were isolated from the strains, and
the alkB gene or the CYP153A6 gene fdrA6 and fdxA6 operons
were replaced with the wild-type sequence by cloning before
being mated into the wild-type host. Furthermore, potentially
improved hydroxylase genes were recloned into a wild-type
vector and transferred into a wild-type host.
Comparison of all the resulting strains in growth assays led
to the identification of several improved hosts and vectors.
Strain Pcyp1, an adapted P. putida GPo12(pGEc47B) strain,
showed faster growth on pentane than its parent when com-
plemented by the wild-type pCom8_cyp153A6 plasmid. Fur-
ther adaptation of Pcyp1 led to Pcyp2, which again grew faster
on pentane. Similarly, strain Palk1 showed improved growth
on propane and butane when transformed with wild-type
pCom10_alkB. For the CYP153A6 system, adapted plasmid
pCom8* enabled faster growth of P. putida GPo12(pGEc47B)
on pentane, even when it contained the wild-type operon. Se-
quencing showed no mutation of the CYP operon in
pCom8*_cyp153A6 or in the sequence 500 nucleotides up- and
downstream from the operon. For the AlkB system, no im-
proved vectors were obtained. The adapted host and vector
components were specific for the particular system used, i.e.,
strain Palk1 did not show improved growth on short-chain-
length alkanes compared to the wild-type host when comple-
mented with CYP153A6. Likewise, Pcyp1, Pcyp2, and pCom8*
were only adapted for their specific systems. The nature of the
mutations and how they benefit growth on short-chain alkanes
is unknown.
In addition to creating these adapted hosts and plasmid, the
first rounds of in vivo-directed evolution generated enzyme
variants AlkB-BMO1 (butane monooxygenase) and CYP153A6-
BMO1, both of which conferred improved growth on butane.
Sequencing revealed a single nucleotide mutation in each: mu-
tation of the codon CTA to GTA led to the single amino acid
substitution L132V in AlkB-BMO1 and, through a GCA-to-
GTA change, the substitution A94V in CYP153A6-BMO1
(A97V in the published sequence reported in reference 9) (see
Materials and Methods).
All the adapted components were combined and evaluated
in plate growth tests (Table 2; Fig. 2). Palk1 expressing AlkB-
BMO1 showed a significant increase in the rate of growth on
butane compared to Palk1 expressing wild-type AlkB. In con-
trast, growth rates on pentane and octane were reduced. No
significant growth improvement on propane was observed, and
neither enzyme supported growth on ethane. These results
suggest that the L132V mutation in AlkB-BMO1 specifically
improves activity toward butane. A similar result was found for
Pcyp2 (pCom8*_cyp153A6-BMO1) recombinants, which grew
more slowly on octane than Pcyp2 (pCom8*_cyp153A6) but
faster on pentane. The CYP153A6-BMO1 variant also sup-
ported growth on butane, which wild-type CYP153A6 does
not. Thus, the A94V mutation appears to specifically enhance
activity on the smaller alkanes.
Plasmids pCom8*_cyp153A6-BMO1 and pCom10_alkB-BMO1
were subjected to a second round of mutagenesis and mated
into Pcyp2 and Palk1, respectively. A further-improved AlkB
monooxygenase, AlkB-BMO2, was obtained after enrichment
and screening. Sequencing revealed a total of three nucleotide
mutations, all resulting in amino acid substitutions in AlkB-
BMO2: V129M (GTG to ATG), L132V (CTA to GTA), and
I233V (ATC to GTC). To ensure comparison in identical ge-
netic backgrounds, the mutated gene was recloned into a wild-
type pCom10 vector, mated into fresh Palk1, and compared in
growth tests to Palk1 expressing wild-type AlkB and AlkB-
BMO1 (Table 2; Fig. 2). Compared to its parent AlkB-BMO1,
AlkB-BMO2 performed even better in growth complementa-
tion studies with butane. Growth on pentane and octane was
also improved but was still inferior to that obtained with the
FIG. 2. Growth of P. putida GPo12(pGEc47B) strains on alkanes.
(A) Strains of adapted P. putida GPo12(pGEc47B) complemented by
an empty plasmid or expressing CYP153A6 wild-type or CYP153A6-
BMO1 (left, middle, and right sections) were grown for 5 days with
butane as sole carbon source. (B) Growth of adapted P. putida
GPo12(pGEc47B) strains complemented by an empty plasmid, ex-
pressing the AlkB wild type, or its variants, BMO1 and BMO2, on
butane after 2 days.
TABLE 2. Relative growth of adapted P. putida GPo12(pGEc47B)
strains, expressing CYP153A6 and AlkB variants, on minimal
medium plates with alkanes as the sole carbon source
Complementing alkane
monooxygenase
Days required for growth to full lawn with
selected carbon source
Ethane Propane Butane Pentane Octane
AlkB wild type NGa 5 5 3 2
AlkB-BMO1 NG 5 3 6 7
AlkB-BMO2 NG 5 2 4 8
CYP153A6 wild type NG NG NG 2 2
CYP153A6-BMO1 NG NG 5 1.5 5
a NG, no growth detected during 3-week observation.
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wild-type enzyme. Thus, the mutations V129M and I233V im-
proved the overall activity of AlkB-BMO2 compared to its
parent, AlkB-BMO1. Enrichment and screening yielded no
additional improvement in the CYP153A6 system.
Whole-cell bioconversions in E. coli confirmed improved
performance of AlkB-BMO1, -BMO2, and CYP153A6-BMO1
for conversion of butane to 1-butanol. In order to quantify the
effects of the mutations on enzyme performance, whole-cell
bioconversions were performed using growth-arrested E. coli
BL21(DE3) cells containing the CYP153A6 variants expressed
from pCom8*. Although pCom plasmids are not efficient ex-
pression platforms, we nonetheless observed CYP153A6 ex-
pression in E. coli, as indicated by the CO difference spectral
peak at 450 nm (Fig. 3). In contrast, no 450-nm signal was
observed for cells harboring the empty pCom8* plasmid. Cy-
tochrome P450s are notoriously difficult to express, and it has
been reported that the CO-binding activity of CYP153A6 is
lost shortly after cell disruption at room temperature, even
when the enzyme is isolated from its native host (33). However,
we found CYP153A6 was expressed well in E. coli DH5 and
showed a stable CO difference spectrum for hours at room
temperature if protease inhibitor was added before cell disrup-
tion (data not shown). Using E. coli BL21(DE3) cells, which
are deficient in the Lon and OmpT proteases, eliminated the
need to add protease inhibitor for stable CYP153A6 expres-
sion. Cell extract from these cultures, expressing CYP153A6 or
CYP153A6-BMO1, retained full CO-binding capacity for 24 h
when stored at 25°C. At 45°C, CO-binding capacity decreased
with time, showing a half-life of 638 min (	68 min [standard
error]) for cell extract containing CYP153A6-BMO1 and 367
min (	58 min) with CYP153A6 (see Fig. S2 in the supplemen-
tal material).
The typical concentration of folded CYP153A6 in the cell
suspensions used for bioconversions was 0.1 to 0.2 M, with
CYP153A6-BMO1 usually expressing 
20% less than its par-
ent, CYP153A6 (Fig. 3). For both enzymes, we observed no
significant decrease in apparent P450 concentration after the
60-min bioconversion reactions (data not shown). Bioconver-
sion studies showed significantly altered activity and selectivity
for CYP153A6-BMO1 that closely followed its growth comple-
mentation performance (Fig. 4A). Control bioconversions per-
formed under the same conditions but using transformants of
empty pCom8* vector did not produce alkanols (data not
shown). Butane bioconversions yielded an averaged total con-
centration of 393 M 1-butanol in the aqueous phase after 60
min with CYP153A6-BMO1, versus 277 M with wild-type
CYP153A6 (Table 3). From the concentration of product
formed divided by the concentration of folded P450, the aver-
age turnover rate of CYP153A6-BMO1 in 1-butanol produc-
tion was 49 min1, a 75% increase compared to 28 min1 for
CYP153A6. Interestingly, the selectivity for terminal hydroxy-
lation also increased with the variant, from 78% to 89% of
total alkanol product. The A94V mutation also improved ac-
tivity and selectivity for conversion of pentane to 1-pentanol
but had the opposite effect with propane and octane.
Since E. coli cells expressing only AlkB showed no product
FIG. 3. CO difference spectra of lysed E. coli BL21(DE3) cell sus-
pensions. E. coli BL21(DE3) cultures expressing CYP153A6 or
CYP153A6-BMO1 were concentrated 5:1 in buffer, and UV-VIS spec-
tra were obtained from the cell extracts after CO saturation. The peaks
correspond to 0.21 M and 0.17 M folded P450 for the CYP153A6
and CYP153A6-BMO1 samples, respectively. Cells carrying the empty
vector treated in the same way served as the negative control.
FIG. 4. Bioconversions of alkanes to 1- and 2-alkanols. Whole-cell
bioconversions were carried out with at least two replicates using
resting E. coli BL21(DE3) cells after expression of CYP153A6 (A) and
AlkB (B) variants. Relative enzymatic activities in the aqueous cell
suspension were calculated from the alcohol product formed per
minute and the enzyme concentration (A) or total cell dry weight (B).
The lower graphs represents relative activities for 1-alkanol, and the
upper part shows 2-alkanol production (if detected). Sole added car-
bon sources were propane (C3), butane (C4), pentane (C5), and octane
(C8). White graphs depict wild-type activity, light gray shows the
BMO1 activity, and dark gray shows the BMO2 variant activities.
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formation, bioconversions were performed using cells trans-
formed with pCom8_alkBFG. Minak-Bernero et al. (18) dem-
onstrated that the AlkBFG system, including the monooxygen-
ase AlkB and the nonessential and essential rubredoxins AlkF
and AlkG, is functional in E. coli, without the need for the
rubredoxin reductase AlkT. Results of bioconversions using
AlkB, AlkB-BMO1, and AlkB-BMO2 (Fig. 4B) showed that
the activity of the variants was greater than that of the wild type
on butane, the substrate used for in vivo evolution, while per-
formance on pentane and octane was decreased. The evolved
variants also showed increased activity on propane, the only
change in activity that was not reflected in a similar observable
change in growth complementation performance.
In 30 min, butane bioconversions utilizing AlkB, AlkB-
BMO1, or AlkB-BMO2 produced on average 630 M, 1030
M, and 1580 M 1-butanol in the aqueous phase, respec-
tively. The dry cell weights of the cell suspensions used for the
bioconversions ranged from 3.0 to 4.0 g/liter. The activities (in
mol of 1-butanol min1 g [cell dry wt]1) thus increased from
6.1 to 9.5 and 15.7 units, respectively. Bioconversions with
AlkB variants were highly regioselective, producing no detect-
able 2-alkanol from propane and pentane and very little
2-alkanol from butane and octane (Table 3).
DISCUSSION
Advantages and drawbacks of in vivo evolution of terminal
alkane hydroxylases. An in vivo-directed evolution system with
selection for terminal alkane hydroxylase activity has been
developed and applied to engineering enzymes from the AlkB
and CYP153 families. The goal of this work was to increase
activity on short-chain alkanes while maintaining these en-
zymes’ remarkable preferences for the thermodynamically dis-
favored terminal position, thereby taking a first step toward
engineering small-alkane hydroxylases that can be expressed in
a recombinant bacterial host amenable to further engineering.
Evolution in vivo using growth selection enables searches
through as many as 108 mutants in a simple flask culture while
exerting selection pressure for many useful enzyme character-
istics simultaneously (e.g., substrate specificity, regioselectivity,
specific activity, coupling of cofactor utilization to product
formation, or expression level). In this particular case, the
Pseudomonas host used for the directed evolution only utilizes
primary alcohols, allowing selection directly for terminal hy-
droxylation. This is the only method we know of for efficient,
high-throughput selection or screening of this important activ-
ity. Previous efforts to engineer P450 BM3 or P450cam for
alkane hydroxylation resulted in enzyme variants mainly tar-
geting subterminal positions (8, 36). The present system prom-
ises to be useful for the directed evolution of a range of alkane
hydroxylases, since P. putida GPo12(pGEc47B) can be com-
plemented for growth on alkanes by many different AlkB and
CYP153 genes (26, 31). Furthermore, growth tests showed that
the host can utilize 1-alkanols down to ethanol, potentially
enabling enrichment for activity on alkanes as small as ethane.
This growth selection system could handle a mutation rate
perhaps 10 times greater than the 0.1 to 0.4 nucleotide changes
per kb obtained using the mutator strains. The P. putida GPo12
organism and the components used in this study, however, are
somewhat difficult to handle with regard to growth stability,
expression, mutation rates, cloning, and transformation effi-
ciency. Furthermore, in vivo evolution also has limits for iden-
tifying moderately improved variants, since enrichment to pure
culture may require weeks or months of continuous culturing,
depending on the actual doubling time on a given substrate
and the level of improvement over the parent. This makes
the stepwise accumulation of small improvements more
challenging.
AlkB enables P. putida GPo12(pGEc47B) to grow on pro-
pane and butane and can be improved in this function. Our
results prove that propane and butane are substrates of AlkB
from P. putida GPo1, verifying earlier assumptions (12). No
growth complementation was observed on ethane, and the E.
coli system utilized in the bioconversion reactions could not be
used to determine whether ethane is converted to ethanol by
AlkB variants, because the glycerol added to allow NADH
regeneration was fermented to ethanol by the E. coli BL21(DE3)
host. Quantification of AlkB activity on ethane would require
purification and reconstitution of AlkB and its electron trans-
port system or genetic modification of the strain used for
whole-cell bioconversions.
Second-generation variant AlkB-BMO2 supported signifi-
cantly better growth and butane bioconversion, more than dou-
ble that of wild-type AlkB. Although specific activity (moles of
product/moles of enzyme/minute) could not be determined for
the AlkB variants, absolute 1-butanol production rates in bio-
conversion reactions were significantly higher for the AlkB-
BMO2 system (up to 1.6 mM in 30 min) than for CYP153A6-
BMO1 (0.4 mM in 60 min). The higher product formation rate
with the AlkB system was surprising, in view of the fact that
it relied on a nonnative E. coli host reductase, while the
CYP153A6 system contained the complete native electron
transfer chain with its ferredoxin and ferredoxin reductase. In
earlier studies, AlkB activity in E. coli cells increased from 3 U
to 20 U when the specific reductase, encoded by alkT, was
present (29). However, the significantly higher E. coli whole-
cell bioconversion rates with AlkB variants did not translate
into better growth complementation of adapted P. putida
GPo12(pGEc47B) strains. It is known that AlkB expresses 2-
to 10-fold better in E. coli than in P. putida. On the other hand,
AlkB has a five- to sixfold-higher specific activity in P. putida
(28). Thus, a possible explanation for the growth complemen-
tation is that the CYP153 variants express better or have a
higher specific activity in P. putida compared to the AlkB
TABLE 3. Absolute product concentrations after bioconversion in
resting E. coli BL21(DE3) cells
Substratea
Total hydroxylated product (M)b
CYP153A6 CYP153A6-BMO1 AlkB
AlkB-
BMO1
AlkB-
BMO2
Propane 421 (59) 244 (68) 625 (0) 1,048 (0) 973 (0)
Butane 356 (22) 439 (11) 639 (1) 1,045 (1) 1,586 (1)
Pentane 260 (62) 374 (49) 606 (0) 294 (0) 317 (0)
Octane 78 (3) 69 (46) 1,122 (9) 487 (2) 308 (1)
a Bioconversions with propane and butane were performed in a bioreactor for
30 min with AlkB variants and for 60 min with CYP153A6 variants. Bioconver-
sion mixtures with pentane and octane were shaken in a glass vial for 60 min for
all enzymes.
b Values in parentheses are the percentage of 2-alkanol in the total hydroxy-
lated product. Only 1- and 2-alkanols were formed in detectable amounts.
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variants. Furthermore, the twice-adapted host Pcyp2 might
contain chromosomal improvements that are able to com-
pensate for the lower apparent butane oxidation activity of
CYP153A6-BMO1 and thus achieve the same growth rate on
butane as Palk1 expressing AlkB.
Although no crystal structures are available for any enzyme
of the AlkB family, a topology model (34, 35) has been pub-
lished. Mapping of the evolved AlkB variant mutations on that
model (Fig. 5) showed that two of the three mutations gener-
ated in AlkB-BMO2, V129M and L132V, are close to the
histidine-containing sequence motif A (H138EXXHK143),
which is one of four highly conserved histidine-containing mo-
tifs in AlkB believed to coordinate the Fe ions and presumed
to be part of or close to the active site (24, 35). Thus, a direct
effect of V129M and L132V on the active site of AlkB seems
possible. The third amino acid substitution, I233V, is located
close to the periplasm in the sixth predicted transmembrane
domain, distant from the active site.
CYP153A6-BMO1 constitutes the first functional butane
monooxygenase of the CYP153 family. Evolved CYP153A6-
BMO1 is the first CYP153 shown to hydroxylate butane and
enable its host to grow on this short-chain-length alkane. The
gaseous alkanes are usually processed by distinct, specialized
enzymes, like the di-iron methane and butane monooxygenases
(30) that are unrelated to the cytochrome P450s. Complemen-
tation of P. putida GPo12(pGEc47B) with various CYP153
wild-type enzymes resulted in growth on alkanes ranging from
pentane to decane (31), but never on butane (unpublished
results). And, until now, biotransformations using CYP153 en-
zymes have only demonstrated activity for hexane and longer
alkanes (9, 10, 14). Here we demonstrated that CYP153A6
wild-type and CYP153A6-BMO1 act on butane and even pro-
pane, but only the BMO1 variant complemented growth of
Pcyp2 on butane. The activity for 1-butanol formation of 49
min1 (0.8 s1) measured in CYP153A6-BMO1 assays is still
less than that reported for the methane monooxygenase from
Methylosinus trichosporium OB3b (8.8 s1) (7), although these
values were generated under very different reaction conditions.
Not only does CYP153A6-BMO1 exhibit increased total activ-
ity on butane compared to its wild-type parent, but its prefer-
ence for terminal hydroxylation also increased, resulting in
only 11% 2-butanol formation compared to 22% for the wild-
type enzyme. CYP153A6-BMO1 was converted into a genuine
butane monooxygenase by in vivo-directed evolution.
CYP153A6-BMO1 contains a single amino acid substitu-
tion, which corresponds to A97V in the published structure
model (9). This mutation, which has a slightly negative effect
on expression level (the CYP153A6-BMO1 variant usually
showed 
80% of the CO-binding activity of the wild type)
stabilized CYP153A6 and nearly doubled its half-life at 45°C.
However, this effect is unlikely to explain the higher observed
bioconversion rates, since both enzymes were stable at 25°C,
and no loss of folded P450 was observed at the end of the
bioconversions. These findings argue for a direct positive effect
of the A97V substitution on the butane hydroxylation activity.
Based on a proposed model of CYP153 (9), however, A97 is
predicted to be located in a loop distant from the active site,
pointing toward the protein surface and not the substrate chan-
nel (Fig. 5). Why the activity of CYP153A6 and CYP153A6-
BMO1 on propane, as observed in the E. coli bioconversion
experiments, is not accompanied by growth complementation
of Pcyp2 on propane remains unknown. A minimum activity
required for growth may not have yet been reached. It is also
possible that the substrate is not available at a sufficient con-
centration or is toxic.
The appearance of improved variants of AlkB and CYP153A6
demonstrated that in vivo evolution in adapted P. putida GPo12
(pGEc47B) can be applied to very different monooxygenase
enzymes. Despite the higher absolute activity and better regi-
oselectivity of AlkB variants in the bioconversion experiments,
the CYP153A enzymes nonetheless offer some important ad-
vantages for further engineering. CYP153 enzymes are soluble,
and accurate determination of functional expression and con-
centration is easier due to observable CO binding. Further-
more, CYP153 proteins have been shown to function in whole-
cell bioconversions as single-component, self-sufficient fusion
proteins with the P450RhF reductase domain (14, 21) as well
as with the CYP102A reductase domain (unpublished results).
Further directed evolution of terminal alkane hydroxylases like
FIG. 5. Models for AlkB (A) and CYP153A6 (B). (A) Topology
model of AlkB, taken from van Beilen et al. (35). Variants AlkB-
BMO1 and AlkB-BMO2 with increased activity on butane carry
L132V and V129ML132VI233V mutations (marked by white cir-
cles), respectively. Amino acids 129 and 132 are close to the first of
four histidine-containing sequence motifs (A to D) that contribute to
coordination of the Fe ions. Position 233 is located in the periplas-
mic end of the sixth transmembrane domain (numbers 1 to 6).
(B) CYP153A6 structural model with bound substrate octane
(spherical object), modified from Funhoff et al. (9). CYP153A6-
BMO1 carries a mutation corresponding to A97V in the model.
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AlkB or CYP153A6 should help us to better understand and
utilize their remarkable catalytic activities.
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